ENB-812

N/A

Report date: 2023/12/15 11:19:47
NME

Base Information

Drug NameENB-812
Drug Alias NameENB-812
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase inhibitors
TargetsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsOvarian Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEngine Biosciences Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEngine Biosciences Pte Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsLung NeoplasmsOvarian Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A